Skip to content
OpenCapital
Get started

Bausch Health Companies BHC Solta Medical — Revenue

Other segment segments

Bausch + Lomb
$1.24B+9.4%
Salix
$639M+17.9%
International
$285M+8.8%
Diversified
$185M-9.8%

Similar metrics at other companies

Novanta logo
NOVTMedical Solutions — Revenue
$126.46M+14.8%
Aveanna Healthcare Holdings Inc. logo
AVAHMedical Solutions — Revenue
$45.65M+7.4%
McKesson logo
MCKMedical-Surgical Solutions — Total revenues
$2.87B+0.5%
Mirion Technologies logo
MIRMedical Segment — Total revenues
$72.1M+5.1%
Bausch + Lomb logo
BLCOSurgical — Total revenues
$228M+6.5%
TFX
TFXSurgical — Net revenues
$106.79M+12.4%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%—
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%—
Debt / equity45.2×—
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's solta medical — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's solta medical — revenue?
Bausch Health Companies (BHC) reported solta medical — revenue of $171M in Q1 2026.
How has Bausch Health Companies's solta medical — revenue changed year-over-year?
Bausch Health Companies's solta medical — revenue increased by 51.3% year-over-year, from $113M to $171M.
What is the long-term trend for Bausch Health Companies's solta medical — revenue?
Over 4 years (2021 to 2025), Bausch Health Companies's solta medical — revenue has grown at a 13.9% compound annual growth rate (CAGR), from $308M to $518M.
What does solta medical — revenue mean?
Total gross income generated from the sale of products and services within the Solta Medical segment, excluding applicable taxes. This is a primary indicator of the segment's market demand and commercial success in the medical aesthetics space.